2017

03/13/2017 Gadolinium-based Contrast Agents: update on PRAC recommendations

Villepinte, March 13, 2017 - Guerbet takes note of the recommendations issued by the Pharmacovigilance Risk Assessment Committee (PRAC), on Gadolinium-based Contrast Agents - procedure under Article 31 of Directive 2001/83/EC.

[more]


02/27/2017 ECR 2017: Guerbet will be there!

ECR 2017 | Expo Hall X2 – Booth 21 | from March 1 to 5 | Austria Center Vienna ӏ Vienna (Austria)

[more]


02/16/2017 Explore 90 years of passion on guerbet90.com

As part of the “90 Years of Passion” campaign, Guerbet is launching a website, guerbet90.com, on the birth date of its founder, André Guerbet.

[more]


02/15/2017 2016 Annual Revenue: €788.8 million, +7.1% growth in Q4

Objective of a sales turnaround after the CMDS acquisition achieved. Growth in revenue in the fourth quarter for all activities and all geographic regions.

[more]